Immunity for Health 2017


On October 20th 2017 Flanders Vaccine is happy to host its second edition of “Immunity for Health”: the Flanders Vaccine annual flagship event where all stakeholders, both from the human and animal health sector, working in the field of immunology, vaccinology, immune-oncology and infectious diseases are invited to meet, interact and start collaborations.

The theme of this year’s edition is “Learning the rules of the immune system: a translational approach“. We are honoured to welcome some internationally renowned experts in the field and are looking forward to be inspired by their talks!

Venue: Elzenveld, Lange Gasthuisstraat 45, 2000 Antwerpen (Attention! Leien closed in both directions: click here to plan your route to Antwerp)

Registration starts at 8:00.

Programme – October 20th, 2017:

OPENING SESSION Orchestrating immune responses in humans and animals to prevent and treat disease – many challenges, one health (Auditorium)

Chair: Sven Arnouts, Chairman of the Board, Flanders Vaccine

08:45    WELCOME

09:00    OPENING KEYNOTE IVaccination strategies from a “One Health” perspective

               Ab Osterhaus, Director Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Germany

09:30    KEYNOTE II Systems Vaccinology: Enabling rational vaccine design with systems biological approaches

               Helder Nakaya, Assistant Professor University of Sao Paulo, Brazil and Adjunct Professor of Emory University, USA

10:00    KEYNOTE III Using dendritic cells as immune orchestrators for therapeutic vaccination of cancer patients

               Evelien Smits, Professor Tumor Immunology, University of Antwerp & Antwerp University Hospital

10:30    COFFEE BREAK (Looking for a sponsorship opportunity? Please contact us!)


MORNING SESSION II – Enhancing the value of clinical trials starts with sharing data & experiences – let’s do so (Auditorium)

Chair: Pierre Van Damme, Flanders Vaccine track lead Clinical trials

Discussion panel: Evelien Smits, Timo Vesikari (tbc), Corinne Vandermeulen

10:50    Clinical trials: State of play at EU and national level

               Greet Musch, Director General PRE Authorisation, FAMHP

11:10     University of Tampere Vaccine Research Center: Concept and Achievements

               Timo Vesikari, Director Vaccine Research Center, University of Tampere, Finland

11:40    Pitch your clinical research – vaccines & immunotherapeutics

11:40    CriPec® Nanomedicines for Superior Therapeutic Performance

               Dr. Marielle Thewissen, senior scientist translational medicine, Cristal Therapeutics

11:50    Next generation immunotherapeutics

               Pierre Vandepapelière, CEO & CMO, Imcyse

12:00    Myasterix, an immunotherapy for myasthenia gravis

               Nicolas Havelange, Chief Operating Officer, Curavac

12:10     short panel discussion

12:20    LUNCH


AFTERNOON SESSION I: The power of the porcine immune system – learning from different worlds (Auditorium)

Chair: Hugo Van Heuverswyn, Flanders Vaccine track lead R&D

13:50    Comparative pig, mouse and human immunomics; similarities, peculiarities and priorities

               Harry Dawson, Senior Research Scientist USDA/ARS, Beltsville Human Nutrition Research Center, USA

14:20    Therapeutic vaccine development in the porcine model

               Gregers Jungersen, Professor Adaptive Immunology and Vaccinology, National Veterinary Institute, Technical University of Denmark

14:50    R&D track launches call for action + Pitch your collaboration incentive

               Hugo van Heuverswyn, Member of the Board, Flanders Vaccine




CLOSING SESSION: Fostering innovation & developing new preventive and therapeutic tools takes joint efforts (Auditorium)

Chair: Henk Joos, Flanders Vaccine track Regional & International visibility

15:50    Human Vaccines Project: accelerate development of vaccines and immunotherapies by decoding the immune system

               Georges Thiry,  PhD, PMP, Consultant, representing the Human Vaccines Project

16:10    Overview of the Vaccine landscape in Belgium

               Stéphanie Mali, Coordinator Center of Excellence for Vaccines, FAMHP

               Laurence Timmermans, International affairs, BioWin

16:30    CLOSING KEYNOTE IV – Perspectives of a young female cancer survivor on the importance of health awareness

               Stefanie Veraghtert, Project Officer at “Kom op tegen Kanker” and founder of Big C – Coffee for Cancer

17:00    Closing remarks

               Sven Arnouts, Chairman of the Board, Flanders Vaccine